View Clinical Trial (Medical Research Study)

Impact of Vitamin D Supplementation on Lactation Associated Bone Loss - NCT00903344-66160(Clinical Trial 292925)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Kansas City
State:  
MO
Zip Code: 66160
Conditions: Osteoporosis
Purpose: Studies have shown that lactation is associated with a loss of bone density from four to seven percent at the spine and hip among women who lactate for six months. Decline in bone density with lactation occurs rapidly. Although bone density increases after weaning, there is controversy on whether or not it is completely restored. Epidemiological studies find no significant negative impact of lactation on bone mass or fractures, and in fact there is evidence that lactation has a positive effect on bone mass. We think that interventions that attenuate this physiologic loss of bone that is associated with lactation and accelerate restoration of bone mass after weaning may result in improved long term bone mass and diminished fracture risk.
Study summary: Adequate vitamin D stores are necessary for skeletal health. Vitamin D deficiency is pronounced in women of child bearing age as well as pregnant women in the United States. This study will provide important information about whether vitamin D supplementation may positively impact the normal physiologic loss of bone mass that is observed during lactation. Recruitment will begin while subjects are pregnant in order to expedite entry into the study in the immediate post-partum period. If subjects are deemed eligible during pregnancy, contact information to include name, address, expected delivery date and two contact phone numbers will be obtained. Subjects will be contacted two weeks prior to expected delivery date and then again at expected delivery date. Subjects will be followed for a total of 18 months.
Criteria: Inclusion Criteria: - Fully lactating mothers age 18 and up - Within 1 month after delivery - Plan to breast feed for at least 6 months Exclusion Criteria: - Known metabolic bone disease - Chronic renal insufficiency - Chronic corticosteroid use - Eating disorder - Estrogen containing hormonal contraception use - Daily use of >400IU Vitamin D supplementation - Delivery of Multiples - Delivery of a singleton with a birth weight of <2500 grams - Preterm delivery of baby - History of kidney stones
Study is available at: University of Kansas Medical Center
Kansas City, MO 66160
United States

Primary Contact:
Leigh Eck, MD
Email: LECK2@kumc.edu
Phone: 913-588-6022
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.